Regeneron Pharmaceuticals Inc (REGN)
702.02
+6.00
(+0.86%)
USD |
NASDAQ |
Feb 21, 15:34
Regeneron Pharmaceuticals Market Cap: 76.75B for Feb. 21, 2025
View 4,000+ Financial Data Types:
Add
Browse
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
Eli Lilly and Co | 787.56B |
Merck & Co Inc | 225.29B |
Pfizer Inc | 149.33B |
Amgen Inc | 163.19B |
Moderna Inc | 13.57B |
Market Cap Related Metrics
PE Ratio | 18.34 |
PS Ratio | 5.688 |
PEG Ratio | 1.805 |
Price to Book Value | 2.615 |
Price to Free Cash Flow | 22.83 |
Price | 702.02 |
Earnings Yield | 5.45% |
PEGY Ratio | 1.805 |
Operating PE Ratio | 19.74 |
Normalized PE Ratio | 18.39 |